Company page

Arcus Biosciences, Inc.

Arcus Biosciences, Inc. (ticker: RCUS) is a public company based in the United States, with a market capitalization of approximately $3.06 billion. The company focuses on developing innovative cancer therapies and treatments. As a player in the biotechnology sector, Arcus aims to advance its pipeline of drug candidates to improve patient outcomes in oncology.